Hyloris Pharmaceuticals SA (EBR:HYL)
Belgium · Delayed Price · Currency is EUR 7.60
-0.02 (-0.26%)
Jan 20, 2026, 5:29 PM CET
Hyloris Pharmaceuticals Market Cap
Hyloris Pharmaceuticals has a market cap or net worth of €212.8 million as of January 20, 2026. Its market cap has increased by 25.00% in one year.
Market Cap
212.80M
Enterprise Value
195.33M
Revenue
8.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
€7.60
Market Cap Chart
Since June 29, 2020, Hyloris Pharmaceuticals's market cap has decreased from 244.70M to 212.80M, a decrease of -13.04%. That is a compound annual growth rate of -2.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 19, 2026 | 213.36M | 11.40% |
| Dec 31, 2025 | 191.52M | 4.59% |
| Dec 31, 2024 | 183.12M | -48.71% |
| Dec 29, 2023 | 357.00M | 14.84% |
| Dec 30, 2022 | 310.88M | -30.44% |
| Dec 31, 2021 | 446.90M | 82.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 50.46B |
| argenx SE | 42.45B |
| Financière de Tubize | 10.48B |
| Fagron NV | 1.68B |
| Ion Beam Applications | 410.90M |
| Onward Medical | 202.43M |
| Nyxoah | 186.95M |
| Sequana Medical NV | 32.32M |